Navigation Links
Mexico's First Spinal Implant Using VTi's Interfuse is a Success
Date:1/12/2017

MEXICO’S FIRST SPINAL IMPLANT USING VTI’S INTERFUSE® IS A SUCCESS

VTI, Vertebral Technologies, Inc., announces the successful outcome of the first lumbar fusion procedure in Mexico using the InterFuse® laterally expandable device. Since September 2016, VTI (Vertebral Technologies, Inc.) has partnered with Mexico-based medical product company BioMedical Technologies to bring less-invasive surgical solutions to surgeons and their patients throughout Mexico.

Neurosurgeon Dr. José Antonio Pedrero Gil at the Hospital AIR in Villahermosa, Tabasco region in northern Mexico performed the first InterFuse® procedure on a 38-year old female patient with Grade 2 spondylolisthesis. At three months, the patient is completely pain free and is walking normally.

The InterFuse® spinal implant finally allows surgeons like Dr. Pedrero to implant a large footprint device through a minimally-invasive posterior to tranforaminal with an angled approach of 0° - 35°. The modularity of the implant allows it to be anatomically customized to the patient’s disc space. Dr. Pedrero stated “the InterFuse® device appeals to me because it was easy to use and the large footprint ensures fusion and also eliminates the risk of retropulsion.”

Dr. Pedrero likes to use the InterFuse® device in younger, active patients with acute disc herniation as well as in patients suffering from spondylolisthesis. segmental instability and spinal stenosis. The partnership between Biomedical Technologies and VTI was formally announced at the September AMCICO Spine Congress in Mexico City, organized by AMCICO (Asociacion Mexicana de Cirujanos de Columna / Spine Surgeons Association of Mexico).

VTI Vice President of International Sales, Ben Wasscher stated “Surgeons in over twenty countries around the world have recognized the benefits that the InterFuse modular cage can bring to their patients. The large footprint is especially effective for patients with poorer bone quality in preventing subsidence. It is great that InterFuse is now also available in Mexico.”

ABOUT BIOMED TECH. INTL. (BioMedical).
Founded in 2004, BioMedical Tech. Intl., is a private held company who focuses on bringing high quality medical products and innovative technology to surgeons. Their Sales Operations Centers are located throughout Mexico, in Mexico City (headquarters), Guadalajara, Tijuana, Monterrey, Chihuahua, Merida, Villahermosa, Veracruz, Hermosillo and with a range of Sub-distributors all around the country. BioMedical’s mission is “To allow people to live more fully and healthier by seeking excellent quality in the products we manage, and to deliver unbeatable service at the appropriate time.” For more information for VTI products in Mexico, contact Pedro Montero for sales at: +52 (55) 52638370.

ABOUT VTI (Vertebral Technologies, Inc.)
VTI (Vertebral Technologies, Inc.) is a privately held company based in Minneapolis, MN, USA. VTI is dedicated to the design, development, manufacturing and marketing of medical devices to address painful conditions of the spine through less-invasive surgical approaches. VTI’s products utilize its unique modular-assembly technology to deliver solutions optimized for both surgeons and their patients. VTI sells its InterFuse modular interbody fusion devices worldwide to-date.

For more information visit, http://www.vti-spine.com or contact Brian Thron at marketing(at)vti-spine(dot)com or +1.952-979-1811

Read the full story at http://www.prweb.com/releases/2017/01/prweb13977072.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. First of it's kind Back Pain Relief Clinic grand opening designed to help millions.
2. Vtesse Announces Dosing of First Patient in Australia in Phase 2b/3 Clinical Trial of VTS-270 in Niemann-Pick Type C1 Disease
3. Arterys Receives FDA Clearance For The First Zero-Footprint Medical Imaging Analytics Cloud Software With Deep Learning For Cardiac MRI
4. ProMIS Neurosciences Declares PMN 310 its First Lead Product for Development in Alzheimer’s Disease
5. Base Pair Biotechnologies, Inc. and Nexmos, Inc. Create the First DNA Aptamers that Inhibit Vitamin C Oxidation
6. Biohaven Enrolls First Patient in Pivotal Trial of BHV-4157 in Patients With Hereditary Spinocerebellar Ataxia
7. First Immunotherapy Treatment Guidelines Published for Hematologic and Prostate Cancers
8. Ionis and AstraZeneca Advance First Generation 2.5 LICA Drug into Preclinical Development to Treat Cardiovascular Disease
9. Raindrop Vision Procedure Performed for the First Time in New England
10. OncoSec Announces First Quarter Financial Results for Fiscal Year 2017
11. KBioBox Launches First Genetic Data BioInformatics Portal Accessible to Scientists for Off Target and Gene Edit Design Analysis. (Complimentary Trial)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... Personal eye wash is a basic first ... eye at a time. So which eye do you rinse first if a dangerous substance ... Plum Duo Eye Wash with its unique dual eye piece. , “Whether its ...
(Date:10/11/2017)... ... ... Disappearing forests and increased emissions are the main causes of the evolving ... those living in larger cities are affected by air pollution related diseases. , That ... countries globally - decided to take action. , “I knew I had to take ...
(Date:10/10/2017)... ... October 10, 2017 , ... For the second ... a US2020 STEM Mentoring Award. Representatives of the FirstHand program travelled to Washington, ... from US2020. , US2020’s mission is to change the trajectory of STEM education ...
(Date:10/10/2017)... PA (PRWEB) , ... October 10, 2017 , ... ... year’s recipients of 13 prestigious awards honoring scientists who have ... presented in a scheduled symposium during Pittcon 2018, the world’s leading conference and ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by ... Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to ... USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... Florida , April 11, 2017 ... a security technology company, announces the appointment of independent Directors ... Bendheim to its Board of Directors, furthering the company,s ... ... of NXT-ID, we look forward to their guidance and benefiting ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... to expand at a CAGR of 25.76% during the ... is the primary factor for the growth of the ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem ... technology, application, and geography. The stem cell market of ...
Breaking Biology News(10 mins):